UPDATED May 29, 2024
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CONCORDBIO | ₹1,448.75 | -0.8% | n/a | ₹151.6b | ₹1,617.60 | PE49.8x | E23.0% | 0% | ||
AMPH | US$41.64 | -4.2% | -6.2% | US$2.1b | US$62.60 | PE13.2x | E16.8% | n/a | ||
1SXP | €28.54 | -6.2% | n/a | €4.3b | €35.65 | PE27.2x | E15.0% | 0.5% | ||
VLS | AU$2.26 | -2.6% | 45.8% | AU$126.0m | n/a | PE13.9x | n/a | 4.0% | ||
600285 | CN¥24.37 | 0.2% | 42.2% | CN¥13.7b | n/a | PE22.4x | E15.0% | 3.3% | ||
500488 | ₹26,097.75 | -0.3% | 20.2% | ₹554.6b | ₹27,741.86 | PE46.2x | E10.0% | 1.6% | ||
540737 | ₹604.95 | 2.0% | 78.2% | ₹7.8b | n/a | PE35.4x | n/a | 0.08% | ||
524632 | ₹105.00 | -9.4% | 252.1% | ₹4.6b | n/a | PE24.8x | n/a | 0.1% | ||
AJANTPHARM | ₹2,395.15 | 0.7% | 83.1% | ₹299.1b | ₹2,440.10 | PE36.6x | E13.3% | 1.5% | ||
4015 | ر.س131.00 | -2.4% | n/a | ر.س9.2b | ر.س146.62 | PE29.5x | E14.3% | 2.3% | ||
MANKIND | ₹2,102.40 | -0.2% | 54.6% | ₹842.3b | ₹2,236.93 | PE44x | E15.9% | n/a | ||
BRKR | US$72.55 | -7.3% | 5.0% | US$11.0b | US$83.23 | PE26.3x | E3.6% | 0.3% | ||
NEU | AU$20.72 | 0.05% | 46.4% | AU$2.7b | AU$28.56 | PE16.8x | E1.4% | n/a | ||
A185750 | ₩102,700.00 | 2.7% | 22.3% | ₩1.3t | ₩152,333.33 | PE6.5x | E-21.8% | 1.0% | ||
6600 | HK$18.32 | 0% | 74.5% | HK$11.1b | HK$17.86 | PE9.2x | E4.7% | 0% | ||
524558 | ₹6,079.75 | -3.4% | 121.6% | ₹78.0b | ₹8,300.00 | PE26x | E12.2% | 0.2% | ||
600566 | CN¥38.17 | 0.7% | 20.4% | CN¥35.2b | CN¥52.36 | PE11.8x | E8.5% | 3.4% | ||
530477 | ₹179.60 | -4.6% | 121.4% | ₹5.6b | n/a | PE23.1x | n/a | 0.3% | ||
VRTX | US$441.13 | -1.4% | 36.3% | US$115.3b | US$462.81 | PE28.3x | E10.1% | n/a | ||
6817 | NT$118.50 | -1.3% | 31.4% | NT$2.2b | n/a | PE13.7x | n/a | 5.6% | ||
500420 | ₹2,715.15 | 1.8% | 47.2% | ₹918.9b | ₹2,850.42 | PE55.5x | E20.4% | 1.0% | ||
3933 | HK$9.21 | -2.8% | 33.5% | HK$16.7b | HK$12.34 | PE5.7x | E0.7% | 6.1% | ||
NATCOPHARM | ₹1,041.25 | 3.8% | 68.3% | ₹186.5b | ₹1,022.09 | PE13.4x | E-3.1% | 0.9% | ||
688578 | CN¥57.51 | -2.9% | 105.8% | CN¥25.9b | n/a | PE28.3x | E20.7% | n/a |